Updated Jul 16, 2026
Gold Daniel Allen has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $147.38M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 12.4K | $35.28 | $437K |
| 2026-07-01 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 600.0K | $34.59 | $20.75M |
| 2026-07-01 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 200.0K | $34.44 | $6.89M |
| 2026-07-01 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 325.0K | $34.07 | $11.07M |
| 2026-07-01 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 300.8K | $33.92 | $10.20M |
| 2026-02-14 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 225.0K | $26.50 | $5.96M |
| 2026-02-14 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 150.8K | $26.49 | $3.99M |
| 2026-02-14 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 275.0K | $26.76 | $7.36M |
| 2026-02-14 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 150.0K | $26.72 | $4.01M |
| 2026-02-14 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 425.0K | $26.67 | $11.33M |
| 2025-12-19 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 189.5K | $23.17 | $4.39M |
| 2025-12-19 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 155.1K | $23.02 | $3.57M |
| 2025-12-19 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 432.7K | $23.05 | $9.97M |
| 2025-12-19 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 642.3K | $23.08 | $14.82M |
| 2025-12-19 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 275.0K | $22.93 | $6.31M |
| 2025-11-22 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 175.0K | $20.24 | $3.54M |
| 2025-11-22 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 125.0K | $20.16 | $2.52M |
| 2025-11-22 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 150.0K | $20.20 | $3.03M |
| 2025-11-22 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 850.0K | $20.25 | $17.21M |
| 2025-09-10 | ROIV | Roivant Sciences Ltd. | J — Other acquisition / disposition | 5.3K | $13.77 | $73K |
Gold Daniel Allen is a corporate insider — currently tracked as Insider of Roivant Sciences Ltd. (ROIV). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 19 open-market sales ($147.38M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Gold Daniel Allen profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.